Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...

Researchers led by the Institute of Molecular and Clinical Ophthalmology Basel uncovered disease-causing variants in ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...

The City Health Department is warning residents after increased levels of influenza A and B were detected in the city’s ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

For members of the Religion News Association, this was the kind of dramatic appeal that made the Chicago native the top ...

Arrowhead Pharmaceuticals (ARWR) is back in focus after fresh regulatory approvals for REDEMPLO in China and Canada, along ...

Venkatesan Sundaresan and Imtiyaz Khanday have already moved on to maize, millets. ‘What works with rice is potentially ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.